SLC5A5 and differentiated thyroid carcinoma: The sodium iodide symporter (NIS) mediates iodide uptake for thyroid hormone biosynthesis and has been successfully utilised for decades to deliver radioiodide (RAI) as a targeted therapeutic for differentiated thyroid cancer (DTC) (1).